SOLICITATION NOTICE
B -- Laboratory Lipids Analyses for NHANES
- Notice Date
- 5/15/2014
- Notice Type
- Presolicitation
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2014-N-15808
- Archive Date
- 5/30/2014
- Point of Contact
- Juanita A. Waters, Phone: 7704882933, Natasha Rowland, Phone: 7704882601
- E-Mail Address
-
jvw0@cdc.gov, hee5@cdc.gov
(jvw0@cdc.gov, hee5@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Health and Nutrition Examination Surveys (NHANES) are a series of cross-sectional surveys conducted by the National Center for Health Statistics (NCHS) designed to provide national statistics on the health and nutritional status of the civilian, non-institutionalized U.S. population through household interviews, standardized physical examinations, and the collection of biologic samples in special mobile examination centers. The surveys oversample the two largest race/ethnic minority groups, non-Hispanic blacks and Mexican-Americans, along with other subgroups of the population. This performance-based performance work statement (PBPWS) seeks to obtain laboratory measurements on biologic specimens for total cholesterol, triglycerides, Apo (B), and HDL-cholesterol among participants 6 years and older. Blood specimens are collected in morning, afternoon and evening sessions. For the morning session the participants are required to fast at least 9 hours. Since triglycerides and Apo (B) must be measured on fasting specimens these tests can only be measured from participants examined in the morning session. Since fasting is not a requirement for total cholesterol and HDL-cholesterol measurements these tests will be measured on all participants in all sessions. Total cholesterol and HDL-cholesterol tests will be performed among participants 6 years and older. Triglycerides and Apo (B) tests will be performed among participants 12 years and older. The goals of this component are to: 1) Monitor the prevalence and trends in major cardiovascular conditions and risk factors in the U.S.; 2) Evaluate prevention and treatment programs targeting cardiovascular disease in the U.S. The main element of the cardiovascular disease laboratory component in NHANES is blood lipid levels. Cardiovascular disease is the leading cause of death in the United States. An estimated 4.8 million Americans have congestive heart failure. Increasing prevalence, hospitalizations, and deaths have made congestive heart failure a major chronic condition in the United States. One serum lipoprotein sub-fraction may emerge as independent risk factors for coronary heart disease-Apolipoprotein B. The test was last measured in NHANES III in 1988-91 and 1991-94, 2005 to present, respectively. The data will be used to: 1) Monitor the status of hypertension prevalence, awareness, treatment and control and the success of the National HBP Education Program; 2) monitor the status of hyperlipidemia and the success of the National Cholesterol Education Program; 3) Estimate the prevalence of congestive heart failure and compare to the baseline data from the NHANES I. C.1.2 Objective and Scope C.1.2.1 Objective: The objective of this firm-fixed price competitive negotiated contract with options is to seek laboratories to measure a Lipids profile (LP) from biologic specimens collected at the NHANES exam center and develop a laboratory manual comprised of the following three (3) tasks. Task 1: A cross comparison of 250 NHANES 2014 serum specimens. There will be a five month overlap between this contract and the existing contractor performing the same work. During this overlap period the same specimens will be measured at both laboratories. The test results from each contract will undergo statistical methods that will determine if the results are comparable. This exercise ensures the continuity of data trends over time. Task 1 will be performed within a five-month time frame upon delivery of serum specimens. Task 2: Lipids profile (LP) testing of 2400 -4600 samples each year from NHANES 2015-2019. Task 2 will be completed within eighteen months after the delivery of specimens. Task 3: Laboratory Manual- -
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2014-N-15808/listing.html)
- Place of Performance
- Address: TBD, United States
- Record
- SN03368102-W 20140517/140515235705-012bef544006434356f3ddfd4251555a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |